Withholding antibiotics does not reduce clinical pregnancy outcomes of natural cycle frozen embryo transfers.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
05 2021
Historique:
received: 20 10 2020
revised: 15 11 2020
accepted: 30 11 2020
pubmed: 12 1 2021
medline: 26 8 2021
entrez: 11 1 2021
Statut: ppublish

Résumé

To assess the impact of withholding doxycycline on the success rate of natural cycle frozen embryo transfers (NC-FET). Retrospective cohort study. Single academic institution. Women undergoing 250 NC-FET with euploid blastocysts performed by a single provider. One hundred and twenty-five NC-FET cycles performed after January 2019 without antibiotic administration compared with 125 NC-FET cycles before January 2019 with doxycycline administration. Primary outcome: live birth (LB) or ongoing pregnancy rate (OPR, defined as pregnancies ≥13 weeks); secondary outcomes included positive β-human chorionic gonadotropin (β-hCG) level and clinical pregnancy rate (CPR, defined as the presence of fetal cardiac activity on ultrasound). Each group of women comprised 125 NC-FET during the study period of March 2017 to March 2020. The women's mean age was 36.3 years and mean body mass index was 24 kg/m In this analysis of similar patients undergoing NC-FET by a single provider, withholding doxycycline does not reduce success rates. Given the risks of antibiotics, our findings support withholding their use in NC-FET.

Identifiants

pubmed: 33423784
pii: S0015-0282(20)32706-0
doi: 10.1016/j.fertnstert.2020.11.038
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1225-1231

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Isabel Beshar (I)

School of Medicine, Stanford University, Stanford, California. Electronic address: ibeshar@stanford.edu.

Jasmyn K Johal (JK)

Department of Obstetrics and Gynecology, Lucile Packard Children's Hospital, Stanford University, Palo Alto, California.

Brindha Bavan (B)

Fertility and Reproductive Health Services, Department of Obstetrics and Gynecology, Stanford University, Sunnyvale, California.

Amin A Milki (AA)

Fertility and Reproductive Health Services, Department of Obstetrics and Gynecology, Stanford University, Sunnyvale, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH